Teva Pharmaceutical Finance Netherlands III BV

CUSIP: 88167AAE1 Class: Corporate Bond - Foreign US$

Pacer Advisors, Inc.'s Holding History (CIK: 0001616667)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 138,000 Value ($000) $136 Avg Close Range
Q2 2025
Shares 196,000 Value ($000) $192 Avg Close Range
Q1 2025
Shares 229,000 Value ($000) $222 Avg Close Range
Q4 2024
Shares 461,000 Value ($000) $443 Avg Close Range
Q2 2024
Shares 413,000 Value ($000) $388 Avg Close Range
Q1 2024
Shares 652,000 Value ($000) $610 Avg Close Range
Q4 2023
Shares 652,000 Value ($000) $603 Avg Close Range
Q3 2023
Shares 652,000 Value ($000) $582 Avg Close Range
Q2 2023
Shares 652,000 Value ($000) $584 Avg Close Range